| Melanie Anne Slagle Toney, MA, BS | |
|
402 15th Ave Se Ste 100, Puyallup, WA 98372-3709 | |
| (253) 697-5200 | |
| (253) 697-5145 |
| Full Name | Melanie Anne Slagle Toney |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 402 15th Ave Se Ste 100, Puyallup, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417124868 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL60011807 (Washington) | Primary |
| Provider Name | Multicare Health System |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Barrett's esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is recommended for BE patients, these examinations may fail to identify pre-cancerous dysplasia and early cancers.
GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), today announced that scientists in their Biosciences Lab have been awarded a second round of funding from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to continue research that could reduce the cost and time of sequencing of an entire human genome to less than $1,000, in under a day.
Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.
Travel Award Available to share data with Clinicians and Scientists to advance the diagnosis, treatment, and management of Malignant Hyperthermia-Susceptible Patients April 23-24, 2010 at Mercy Hospital University of Pittsburgh Medical Center.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melanie Anne Slagle Toney, MA, BS 402 15th Ave Se Ste 100, Puyallup, WA 98372-3709 Ph: (253) 697-5200 | Melanie Anne Slagle Toney, MA, BS 402 15th Ave Se Ste 100, Puyallup, WA 98372-3709 Ph: (253) 697-5200 |
News Archive
Barrett's esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is recommended for BE patients, these examinations may fail to identify pre-cancerous dysplasia and early cancers.
GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), today announced that scientists in their Biosciences Lab have been awarded a second round of funding from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to continue research that could reduce the cost and time of sequencing of an entire human genome to less than $1,000, in under a day.
Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.
Travel Award Available to share data with Clinicians and Scientists to advance the diagnosis, treatment, and management of Malignant Hyperthermia-Susceptible Patients April 23-24, 2010 at Mercy Hospital University of Pittsburgh Medical Center.
› Verified 8 days ago
Ms. Angela Farnsworth, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 214 W Main, Puyallup, WA 98371 Phone: 253-841-8700 | |
Mrs. Amrita Nambiar, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 12th Ave Se, Puyallup, WA 98372 Phone: 253-841-3422 | |
Kaara Fairbanks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2929 5th Ave Ne Ste A, Puyallup, WA 98372 Phone: 253-447-8216 | |
Mrs. Nicole Malene Bosch, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 214 W Main, Puyallup, WA 98371 Phone: 253-841-8700 | |
Teletalk Speech Therapy Services Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17442 129th Ave E, Puyallup, WA 98374 Phone: 516-510-5963 | |
Robert Michael Shields, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 402 15th Ave Se Ste 100, Puyallup, WA 98372 Phone: 253-697-5200 Fax: 253-697-5248 | |
Dana Welter, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10324 Canyon Rd E, Puyallup, WA 98373 Phone: 360-584-6918 |